{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:07:56Z","timestamp":1790816876714,"version":"4.1.0"},"reference-count":181,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clbc.2021.02.009","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T15:19:45Z","timestamp":1616080785000},"page":"128-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Prevention of Breast Cancer-Related Lymphedema"],"prefix":"10.1016","volume":"21","author":[{"given":"Maureen P.","family":"McEvoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Ravetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunj","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2021.02.009_bib0001","first-page":"187","article-title":"Lymphatic mapping and preoperative imaging in the management of post-mastectomy lymphoedema","volume":"5","author":"Chowdhry","year":"2016","journal-title":"Gland Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0002","series-title":"Lymphedema: Presentation, Diagnosis and Treatment","first-page":"9","article-title":"Pathophysiology of lymphedema","author":"Hespe","year":"2015"},{"key":"10.1016\/j.clbc.2021.02.009_bib0003","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2021.02.009_bib0004","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/pon.4239","article-title":"Financial cost of lymphedema borne by women with breast cancer","volume":"26","author":"Boyages","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.clbc.2021.02.009_bib0006","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","article-title":"Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study","volume":"27","author":"Shih","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0007","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1524-4741.2012.01252.x","article-title":"Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction","volume":"18","author":"Shah","year":"2012","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2021.02.009_bib0008","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jso.20373","article-title":"The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance","volume":"92","author":"Leidenius","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0009","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archsurg.138.5.482","article-title":"Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer","volume":"138","author":"Blanchard","year":"2003","journal-title":"Arch Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0011","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2012.41.8574","article-title":"Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review","volume":"30","author":"Paskett","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0012","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2021.02.009_bib0013","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/lrb.2014.0035","article-title":"The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study","volume":"12","author":"Soran","year":"2014","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0014","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fonc.2016.00192","article-title":"The impact of L-Dex(\u00ae) measurements in assessing breast cancer-related lymphedema as part of routine clinical practice","volume":"6","author":"Laidley","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0015","doi-asserted-by":"crossref","first-page":"b5396","DOI":"10.1136\/bmj.b5396","article-title":"Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial","volume":"340","author":"Torres Lacomba","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2021.02.009_bib0016","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/cncr.23494","article-title":"Preoperative assessment enables the early diagnosis and successful treatment of lymphedema","volume":"112","author":"Stout Gergich","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0017","first-page":"170","article-title":"The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology","volume":"49","year":"2016","journal-title":"Lymphology"},{"key":"10.1016\/j.clbc.2021.02.009_bib0018","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12609-013-0105-0","article-title":"Best practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema","volume":"5","author":"Armer","year":"2013","journal-title":"Curr Breast Cancer Rep"},{"key":"10.1016\/j.clbc.2021.02.009_bib0019","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/jpm4030424","article-title":"Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema","volume":"4","author":"Ostby","year":"2014","journal-title":"J Pers Med"},{"key":"10.1016\/j.clbc.2021.02.009_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01893697-201432010-00004","article-title":"Breast Cancer EDGE Task Force Outcomes: clinical measures of pain","volume":"32","author":"Harrington","year":"2014","journal-title":"Rehabil Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0021","unstructured":"NLN Medical Advisory Committee. Supplement to the NLN position breast cancer screening: screening and early detection of breast cancer-related lymphedema. Available at: https:\/\/www.nortonschool.com\/reference_library\/publications\/nln_pp_bc_supplement.pdf. Accessed March 13, 2021."},{"key":"10.1016\/j.clbc.2021.02.009_bib0022","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1245\/s10434-017-5982-4","article-title":"Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS panel: part 1: definitions, assessments, education, and future directions","volume":"24","author":"McLaughlin","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0023","first-page":"118","article-title":"Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months","volume":"43","author":"Armer","year":"2010","journal-title":"Lymphology"},{"key":"10.1016\/j.clbc.2021.02.009_bib0024","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ejso.2011.09.001","article-title":"Prevalence of lymphoedema more than five years after breast cancer treatment","volume":"37","author":"Lopez Penha","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0026","unstructured":"National lymphedema Network. Website. Available at: http:\/\/www.nationallymphedemanetwork.org. Accessed March 13, 2021."},{"key":"10.1016\/j.clbc.2021.02.009_bib0027","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1078-5884(96)80005-0","article-title":"Infrared optoelectronic volumetry, the ideal way to measure limb volume","volume":"12","author":"Tierney","year":"1996","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10549-018-4902-z","article-title":"Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema","volume":"172","author":"Sun","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0029","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/lrb.2017.0039","article-title":"Measuring limb volume: accuracy and reliability of tape measurement versus perometer measurement","volume":"16","author":"Sharkey","year":"2018","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0030","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1245\/s10434-017-5964-6","article-title":"Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema, recommendations from an expert panel: part 2: preventive and therapeutic options","volume":"24","author":"McLaughlin","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0031","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/ptj\/82.12.1201","article-title":"Upper-extremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume","volume":"82","author":"Sander","year":"2002","journal-title":"Phys Ther"},{"key":"10.1016\/j.clbc.2021.02.009_bib0032","first-page":"2","article-title":"Early diagnosis of lymphedema using multiple frequency bioimpedance","volume":"34","author":"Cornish","year":"2001","journal-title":"Lymphology"},{"key":"10.1016\/j.clbc.2021.02.009_bib0033","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10549-015-3357-8","article-title":"Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer","volume":"151","author":"Bundred","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0034","first-page":"85","article-title":"L-Dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity","volume":"46","author":"Fu","year":"2013","journal-title":"Lymphology"},{"key":"10.1016\/j.clbc.2021.02.009_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fonc.2018.00197","article-title":"Preventing breast cancer-related lymphedema in high-risk patients: the impact of a structured surveillance protocol using bioimpedance spectroscopy","volume":"8","author":"Whitworth","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0036","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/tbj.12939","article-title":"Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy","volume":"24","author":"Whitworth","year":"2018","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2021.02.009_bib0037","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-017-4451-x","article-title":"Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema","volume":"166","author":"Kaufman","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0038","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/807569","article-title":"Comparison of breast cancer-related lymphedema (upper limb swelling) prevalence estimated using objective and subjective criteria and relationship with quality of life","volume":"2013","author":"Bulley","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clbc.2021.02.009_bib0039","first-page":"3103","article-title":"Development and validation of the lymphedema symptom and intensity survey-arm","volume":"23","author":"Ridner","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejon.2013.10.006","article-title":"A morbidity screening tool for identifying fatigue, pain, upper limb dysfunction and lymphedema after breast cancer treatment: a validity study","volume":"18","author":"Bulley","year":"2014","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.clbc.2021.02.009_bib0041","first-page":"345","article-title":"Symptom report in detecting breast cancer-related lymphedema","volume":"7","author":"Fu","year":"2015","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.clbc.2021.02.009_bib0042","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.breast.2010.05.015","article-title":"Self-reported arm-lymphedema and functional impairment after breast cancer treatment\u2013a nationwide study of prevalence and associated factors","volume":"19","author":"Gartner","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2021.02.009_bib0043","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1016591121762","article-title":"Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema","volume":"75","author":"Box","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0044","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/annonc\/mdl182","article-title":"A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment","volume":"18","author":"Moseley","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/028418600750013186","article-title":"Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage\u2013a randomized study","volume":"39","author":"Andersen","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0046","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12282-018-0830-3","article-title":"The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study","volume":"25","author":"Zou","year":"2018","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0047","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1055-9965.EPI-09-1245","article-title":"Risk factors for lymphedema after breast cancer treatment","volume":"19","author":"Norman","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2021.02.009_bib0048","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1524-4741.2009.00855.x","article-title":"Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients","volume":"16","author":"Helyer","year":"2010","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2021.02.009_bib0049","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-013-2715-7","article-title":"Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer","volume":"142","author":"Jammallo","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0050","first-page":"853","article-title":"Body mass index and breast cancer treatment-related lymphedema","volume":"19","author":"Ridner","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0051","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10549-013-2655-2","article-title":"Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?","volume":"140","author":"Specht","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0052","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","article-title":"Risk factors for lymphoedema in women with breast cancer: a large prospective cohort","volume":"28","author":"Kilbreath","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2021.02.009_bib0053","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","article-title":"The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study","volume":"88","author":"Warren","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2021.02.009_bib0054","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1200\/JCO.2015.61.5948","article-title":"Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer","volume":"34","author":"Ferguson","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0055","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1016\/S1470-2045(16)30204-2","article-title":"Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis","volume":"17","author":"Asdourian","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0056","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12609-017-0237-8","article-title":"Diagnostic methods, risk factors, prevention, and management of breast cancer-related lymphedema: past, present, and future directions","volume":"9","author":"Sayegh","year":"2017","journal-title":"Curr Breast Cancer Rep"},{"key":"10.1016\/j.clbc.2021.02.009_bib0057","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1245\/s10434-012-2631-9","article-title":"Lifestyle risk factors associated with arm swelling among women with breast cancer","volume":"20","author":"Showalter","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0058","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jamcollsurg.2012.11.004","article-title":"Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery","volume":"216","author":"McLaughlin","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0059","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0060","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","article-title":"The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors","volume":"16","author":"Tsai","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0061","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1200\/JCO.2008.16.3766","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0062","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10549-016-4089-0","article-title":"Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis","volume":"162","author":"Shaitelman","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0063","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/bjs.9846","article-title":"Adjuvant taxanes and the development of breast cancer-related arm lymphoedema","volume":"102","author":"Cariati","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0064","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamasurg.2019.1742","article-title":"Factors associated with lymphedema in women with node-positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection","volume":"154","author":"Armer","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10549-015-3408-1","article-title":"Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort","volume":"151","author":"Swaroop","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0066","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0360-3016(02)04273-6","article-title":"Risk of lymphedema after regional nodal irradiation with breast conservation therapy","volume":"55","author":"Coen","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2021.02.009_bib0067","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1200\/JCO.20.00459","article-title":"Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial","volume":"38","author":"Naoum","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0068","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0069","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2021.02.009_bib0070","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10549-010-1167-6","article-title":"A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance","volume":"125","author":"Wernicke","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0071","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1245\/s10434-010-1217-7","article-title":"Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up","volume":"18","author":"Martelli","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0072","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2021.02.009_bib0073","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejso.2016.01.020","article-title":"Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial","volume":"42","author":"Gentilini","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0074","unstructured":"US Food and Drug Administration. Magtrace and Sentimag Magnetic Localization System approval letter. Available at: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160053a.pdf. Accessed March 14, 2021."},{"key":"10.1016\/j.clbc.2021.02.009_bib0075","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/bjs.11110","article-title":"Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study)","volume":"106","author":"Karakatsanis","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0076","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jso.20905","article-title":"A new concept toward the prevention of lymphedema: axillary reverse mapping","volume":"97","author":"Klimberg","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0077","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/bjc.1992.230","article-title":"Assessment of morbidity from complete axillary dissection","volume":"66","author":"Ivens","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0078","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00000658-199202000-00009","article-title":"The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer. A prospective randomized trial","volume":"215","author":"Somers","year":"1992","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0079","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9","article-title":"Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis","volume":"92","author":"Petrek","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0080","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0360-3016(86)90280-4","article-title":"Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy","volume":"12","author":"Larson","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2021.02.009_bib0081","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/02841860801961257","article-title":"Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy","volume":"47","author":"Nesvold","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0082","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12B+<2817::AID-CNCR32>3.0.CO;2-2","article-title":"Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma","volume":"83","author":"Passik","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0083","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/1097-0142(19931201)72:11<3248::AID-CNCR2820721119>3.0.CO;2-Z","article-title":"The psychological morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema","volume":"72","author":"Tobin","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0084","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K","article-title":"Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma","volume":"88","author":"Schrenk","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/ejso.2002.1327","article-title":"Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer","volume":"28","author":"Haid","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0086","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/BF02574496","article-title":"Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer","volume":"9","author":"Swenson","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0087","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/ejso.2002.1385","article-title":"Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy","volume":"29","author":"Schijven","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0088","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.breast.2004.09.010","article-title":"One-year morbidity after sentinel node biopsy and breast surgery","volume":"14","author":"Ronka","year":"2005","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2021.02.009_bib0089","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1245\/s10434-007-9412-x","article-title":"Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation","volume":"14","author":"Thompson","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0090","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jamcollsurg.2007.12.022","article-title":"Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy","volume":"206","author":"Boneti","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0091","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1245\/s10434-015-4721-y","article-title":"Single institution experience with lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema","volume":"22","author":"Feldman","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0092","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/SLA.0000000000001778","article-title":"Does axillary reverse mapping prevent lymphedema after lymphadenectomy?","volume":"265","author":"Tummel","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0093","first-page":"79","article-title":"Number of lymph nodes examined and the prognosis of breast carcinoma","volume":"131","author":"Fisher","year":"1970","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.clbc.2021.02.009_bib0094","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.1986.4.6.929","article-title":"Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of l-phenylalanine mustard (L-PAM) in the management of primary breast cancer","volume":"4","author":"Fisher","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0095","first-page":"290","article-title":"Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2021.02.009_bib0096","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.breast.2020.08.007","article-title":"Clinical application of axillary reverse mapping in patients with breast cancer: a systematic review and meta-analysis","volume":"53","author":"Wijaya","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2021.02.009_bib0097","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1245\/s10434-007-9450-4","article-title":"Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection","volume":"14","author":"Nos","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0098","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1245\/s10434-008-0030-z","article-title":"Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection","volume":"15","author":"Nos","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0099","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1245\/s10434-009-0554-x","article-title":"Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients","volume":"16","author":"Casabona","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0100","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1200\/JCO.2009.22.1846","article-title":"Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer","volume":"27","author":"Ponzone","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0101","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/cncr.25096","article-title":"A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients","volume":"116","author":"Bedrosian","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0102","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00432-011-1064-3","article-title":"Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients","volume":"137","author":"Deng","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0103","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4048\/jbc.2012.15.1.91","article-title":"The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer","volume":"15","author":"Han","year":"2012","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jso.23048","article-title":"Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer","volume":"106","author":"Rubio","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.22094","article-title":"Axillary reverse mapping using a fluorescence imaging system in breast cancer","volume":"105","author":"Noguchi","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0106","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1245\/s10434-013-3113-4","article-title":"Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer","volume":"20","author":"Connor","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0107","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ejso.2013.09.022","article-title":"Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema","volume":"39","author":"Gennaro","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0108","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejso.2013.05.009","article-title":"Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?","volume":"39","author":"Tausch","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0109","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejso.2014.03.023","article-title":"The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients","volume":"40","author":"Ikeda","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/BD-140371","article-title":"Axillary reverse mapping:is it feasible in locally advanced breast cancer patients?","volume":"34","author":"Khandelwal","year":"2014","journal-title":"Breast Dis"},{"key":"10.1016\/j.clbc.2021.02.009_bib0111","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jso.23720","article-title":"Axillary reverse mapping in breast cancer: a Canadian experience","volume":"110","author":"Kuusk","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0112","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.surg.2014.05.011","article-title":"Axillary reverse mapping: five-year experience","volume":"156","author":"Ochoa","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.clbc.2021.02.009_bib0113","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jso.23528","article-title":"Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies","volume":"109","author":"Sakurai","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0114","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1245\/s10434-014-3626-5","article-title":"Prospective study evaluating oncological safety of axillary reverse mapping","volume":"21","author":"Schunemann","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejso.2014.09.012","article-title":"Axillary reverse mapping (ARM) in clinically node positive breast cancer patients","volume":"41","author":"Beek","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0116","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.clbc.2015.01.010","article-title":"A prospective study to assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients","volume":"15","author":"Yue","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0117","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0972-3919.172341","article-title":"Feasibility study of axillary reverse mapping lymphoscintigraphy in carcinoma breast: a concept toward preventing lymphedema","volume":"31","author":"Gandhi","year":"2016","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.clbc.2021.02.009_bib0118","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jso.24231","article-title":"Axillary reverse mapping in patients with breast cancer: is it oncologically safe?","volume":"113","author":"Ngui","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0119","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejso.2016.02.244","article-title":"Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer","volume":"42","author":"Noguchi","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0120","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.ejso.2016.07.138","article-title":"Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection","volume":"42","author":"Nos","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0121","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13193-016-0578-1","article-title":"Feasibility of axillary reverse mapping and clinicopathological features predicting ARM node metastasis in breast cancer-a pilot study","volume":"8","author":"Kumar","year":"2017","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0122","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13037-019-0217-1","article-title":"Prevention of lymphedema via axillary reverse mapping for arm lymph-node preservation following breast cancer surgery: a randomized controlled trial","volume":"13","author":"Faisal","year":"2019","journal-title":"Patient Saf Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0123","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8637895","article-title":"Relationship between upper extremity lymphatic drainage and sentinel lymph nodes in patients with breast cancer","volume":"2019","author":"Ma","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0124","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1245\/s10434-019-07569-4","article-title":"Identification and preservation of arm lymphatic system in axillary dissection for breast cancer to reduce arm lymphedema events: a randomized clinical trial","volume":"26","author":"Yuan","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejso.2019.08.003","article-title":"A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer","volume":"46","author":"Beek","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0126","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/bjs.10041","article-title":"Systematic review of axillary reverse mapping in breast cancer","volume":"103","author":"Ahmed","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0127","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MNM.0b013e328315a6c6","article-title":"Lymphatic drainage pathways of the breast and the upper limb","volume":"30","author":"Britton","year":"2009","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.clbc.2021.02.009_bib0128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jso.21473","article-title":"Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer","volume":"101","author":"Noguchi","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0129","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.amjsurg.2009.06.008","article-title":"Scientific Impact Award: axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy","volume":"198","author":"Boneti","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0130","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10549-016-3920-y","article-title":"Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status","volume":"158","author":"Beek","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0131","first-page":"421","article-title":"Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy","volume":"64","author":"Boneti","year":"2012","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0132","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2016.03.014","article-title":"Clinical feasibility of axillary reverse mapping and its influence on breast cancer related lymphedema: a systematic review","volume":"200","author":"Gebruers","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0133","article-title":"The feasibility and oncological safety of axillary reverse mapping in patients with breast cancer: a systematic review and meta-analysis of prospective studies","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2021.02.009_bib0134","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ejso.2019.06.009","article-title":"Near-infrared fluorescence imaging for the prevention and management of breast cancer-related lymphedema: a systematic review","volume":"45","author":"Abbaci","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1245\/s10434-008-0270-y","article-title":"Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy","volume":"16","author":"Boccardo","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0136","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1245\/s10434-011-1624-4","article-title":"Surgical prevention of arm lymphedema after breast cancer treatment","volume":"18","author":"Boccardo","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0137","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1245\/s10434-016-5282-4","article-title":"LYMPHA technique to prevent secondary lower limb lymphedema","volume":"23","author":"Boccardo","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0138","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/micr.22254","article-title":"Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up","volume":"34","author":"Boccardo","year":"2014","journal-title":"Microsurgery"},{"key":"10.1016\/j.clbc.2021.02.009_bib0139","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1097\/SAP.0000000000001864","article-title":"Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach","volume":"82","author":"Johnson","year":"2019","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0140","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0141","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000658-199907000-00011","article-title":"Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy","volume":"230","author":"Kuerer","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0142","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0143","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1200\/JCO.2005.07.032","article-title":"Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer","volume":"23","author":"Buzdar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0144","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0146","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0147","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1245\/s10434-016-5246-8","article-title":"How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study","volume":"23","author":"Mamtani","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0148","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0149","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamasurg.2014.1086","article-title":"Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial","volume":"150","author":"Caudle","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0150","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.3747\/co.20.1294","article-title":"Axillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancer","volume":"20","author":"Zhang","year":"2013","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0151","doi-asserted-by":"crossref","first-page":"e1720","DOI":"10.1097\/MD.0000000000001720","article-title":"Prognostic nomogram for prediction of axillary pathologic complete response after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer","volume":"94","author":"Kim","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clbc.2021.02.009_bib0152","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00280-015-2906-5","article-title":"A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin-docetaxel with or without trastuzumab in locally advanced breast cancer","volume":"77","author":"L-Tweigeri","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0153","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","article-title":"Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes","volume":"23","author":"Diego","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0154","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0155","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.clbc.2019.01.013","article-title":"Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+ before neoadjuvant chemotherapy and became cN0 after treatment","volume":"19","author":"Natsiopoulos","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2021.02.009_bib0156","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.ejso.2019.11.501","article-title":"Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery","volume":"46","author":"Allweis","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0157","doi-asserted-by":"crossref","first-page":"452","DOI":"10.20892\/j.issn.2095-3941.2018.0270","article-title":"Comparison of sentinel lymph node detection performances using blue dye in conjunction with indocyanine green or radioisotope in breast cancer patients: a prospective single-center randomized study","volume":"15","author":"Yuan","year":"2018","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.clbc.2021.02.009_bib0158","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2021.02.009_bib0159","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0160","series-title":"San Antonio Breast Cancer Proceedings","first-page":"GS4","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10 year follow up results of the EORTC AMAROS trial (EORTC 10981\/22023)","author":"Rutgers","year":"2019"},{"key":"10.1016\/j.clbc.2021.02.009_bib0161","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/bjs.9952","article-title":"Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer","volume":"103","author":"Bing","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0162","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-014-2856-3","article-title":"Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients","volume":"144","author":"Miller","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.009_bib0163","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1245\/s10434-017-5960-x","article-title":"Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study","volume":"24","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0164","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2018.03.046","article-title":"Radiation therapy field design and lymphedema risk after regional nodal irradiation for breast cancer","volume":"102","author":"Gross","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2021.02.009_bib0165","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2021.02.009_bib0166","doi-asserted-by":"crossref","first-page":"TPS602","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS602","article-title":"Cctg MA.39 tailor RT: A randomized trial of regional radiotherapy in biomarker low-risk node-positive breast cancer (NCT03488693)","volume":"37","author":"Parulekar","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0167","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) Trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0168","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0169","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.18.00982","article-title":"Patient-reported outcomes over 5 years after whole- or partial-breast radiotherapy: longitudinal analysis of the IMPORT LOW (CRUK\/06\/003) phase III randomized controlled trial","volume":"37","author":"Bhattacharya","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0170","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2021.02.009_bib0171","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1200\/JCO.2019.37.15_suppl.508","article-title":"Patient-reported outcomes (PROs) in NRG oncology\/NSABP B-39\/RTOG 0413: a randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer","volume":"37","author":"Ganz","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0172","doi-asserted-by":"crossref","first-page":"m2836","DOI":"10.1136\/bmj.m2836","article-title":"Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial","volume":"370","author":"Vaidya","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2021.02.009_bib0173","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1748-717X-8-9","article-title":"Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A","volume":"8","author":"Welzel","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0174","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/tbj.13574","article-title":"Outcomes with intraoperative radiation therapy for early-stage breast cancer","volume":"26","author":"Obi","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2021.02.009_bib0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1245\/s10434-016-5558-8","article-title":"Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update","volume":"24","author":"Recht","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0176","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clon.2007.10.004","article-title":"Elucidating the role of chest wall irradiation in \u2018intermediate-risk\u2019 breast cancer: the MRC\/EORTC SUPREMO trial","volume":"20","author":"Kunkler","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clbc.2021.02.009_bib0177","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2019.5559","article-title":"Association between 21-gene assay recurrence score and locoregional recurrence rates in patients with node-positive breast cancer","volume":"6","author":"Woodward","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2021.02.009_bib0178","doi-asserted-by":"crossref","first-page":"djw259","DOI":"10.1093\/jnci\/djw259","article-title":"21-Gene recurrence score and locoregional recurrence in node-positive\/ER-positive breast cancer treated with chemo-endocrine therapy","volume":"109","author":"Mamounas","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2021.02.009_bib0179","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2021.02.009_bib0180","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2021.02.009_bib0181","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2021.02.009_bib0182","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/SLA.0000000000002827","article-title":"Evaluation of Simplified Lymphatic Microsurgical Preventing Healing Approach (S-LYMPHA) for the Prevention of Breast Cancer-Related Clinical Lymphedema After Axillary Lymph Node Dissection","volume":"270","author":"Ozmen","year":"2019","journal-title":"Ann Surg."}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921000513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921000513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:21:18Z","timestamp":1761513678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820921000513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":181,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1526820921000513"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2021.02.009","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of Breast Cancer-Related Lymphedema","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2021.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}